Burning Rock Biotech Limited
BNR
$4.60
-$0.10-2.13%
| 09/30/2024 | 03/31/2024 | 12/31/2023 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | 72.75M | 76.09M | 76.09M | 79.33M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 72.75M | 76.09M | 76.09M | 79.33M |
| Cost of Revenue | -- | 23.81M | 24.64M | 24.64M | 24.45M |
| Gross Profit | -- | 48.95M | 51.45M | 51.45M | 54.88M |
| SG&A Expenses | -- | 89.03M | 96.94M | 96.94M | 103.87M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | 157.37M | 170.72M | 170.72M | 181.54M |
| Operating Income | -- | -84.62M | -94.64M | -94.64M | -102.20M |
| Income Before Tax | -- | -81.99M | -92.10M | -92.10M | -99.94M |
| Income Tax Expenses | -- | 299.00K | 335.60K | 335.60K | 454.80K |
| Earnings from Continuing Operations | -- | -82.29 | -92.43 | -92.43 | -100.39 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -82.29M | -92.43M | -92.43M | -100.39M |
| EBIT | -- | -84.62M | -94.64M | -94.64M | -102.20M |
| EBITDA | -- | -67.02M | -77.20M | -77.20M | -85.07M |
| EPS Basic | -- | -80.34 | -90.27 | -90.27 | -98.05 |
| Normalized Basic EPS | -- | -5.00 | -5.62 | -5.62 | -6.10 |
| EPS Diluted | -- | -80.34 | -90.27 | -90.27 | -98.05 |
| Normalized Diluted EPS | -- | -5.00 | -5.62 | -5.62 | -6.10 |
| Average Basic Shares Outstanding | -- | 40.97M | 40.96M | 40.96M | 40.96M |
| Average Diluted Shares Outstanding | -- | 4.10M | 4.10M | 4.10M | 4.10M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
